Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon.

Tchouwa GF, Eymard-Duvernay S, Cournil A, Lamare N, Serrano L, Butel C, Bertagnolio S, Mpoudi-Ngole E, Raizes E, Aghokeng AF; EHRICA Study Group.

EClinicalMedicine. 2018 Jul 4;1:21-27. doi: 10.1016/j.eclinm.2018.06.005. eCollection 2018 Jul.

2.

Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries.

Ngo-Giang-Huong N, Huynh THK, Dagnra AY, Toni TD, Maiga AI, Kania D, Eymard-Duvernay S, Peeters M, Soulie C, Peytavin G, Rekacewicz C, Chaix ML, Aghokeng AF; ANRS 12333 Study Group .

J Antimicrob Chemother. 2019 Feb 1;74(2):462-467. doi: 10.1093/jac/dky443.

3.

Heterogeneity of virological suppression in the national antiretroviral programme of Cameroon (ANRS 12288 EVOLCAM).

Liégeois F, Eymard-Duvernay S, Boyer S, Maradan G, Kouanfack C, Domyeum J, Boyer V, Mpoudi-Ngolé E, Spire B, Delaporte E, Vidal L, Kuaban C, Laurent C; EVOLCAM study group.

HIV Med. 2019 Jan;20(1):38-46. doi: 10.1111/hiv.12681. Epub 2018 Oct 25.

PMID:
30362279
4.

Prevalence of pretreatment HIV drug resistance in Cameroon following a nationally representative WHO survey.

Tchouwa GF, Eymard-Duvernay S, Cournil A, Lamare N, Serrano L, Butel C, Bertagnolio S, Mpoudi-Ngole E, Raizes E, Aghokeng AF; Members of the EHRICA Study Group .

J Antimicrob Chemother. 2018 Sep 1;73(9):2468-2474. doi: 10.1093/jac/dky221.

PMID:
29931063
5.

Short Communication: Nucleoside Reverse Transcriptase Inhibitors with Reduced Predicted Activity Do Not Impair Second-Line Therapy with Lopinavir/Ritonavir or Darunavir/Ritonavir.

Villabona-Arenas CJ, Eymard-Duvernay S, Aghokeng A, Guichet E, Toure-Kane C, Bado G, Koulla-Shiro S, Delaporte E, Ciaffi L, Peeters M.

AIDS Res Hum Retroviruses. 2018 Jun;34(6):477-480. doi: 10.1089/AID.2017.0290. Epub 2018 Apr 23.

PMID:
29575909
6.

HIV is associated with airway obstruction: a matched controlled study.

Makinson A, Hayot M, Eymard-Duvernay S, Ribet C, Raffi F, Pialoux G, Zucman D, Poizot-Martin I, Bonnet F, Abgrall S, Tattevin P, Cheret A, Ferry T, Mauboussin JM, Marchand L, Rouzaud C, Reynes J, Zins M, Le Moing V; ANRS EP48 HIV CHEST study Team.

AIDS. 2018 Jan 14;32(2):227-232. doi: 10.1097/QAD.0000000000001691.

PMID:
29135582
7.

TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study.

Kabore FN, Eymard-Duvernay S, Zoungrana J, Badiou S, Bado G, Héma A, Diouf A, Delaporte E, Koulla-Shiro S, Ciaffi L, Cournil A.

PLoS One. 2017 Nov 8;12(11):e0186686. doi: 10.1371/journal.pone.0186686. eCollection 2017.

8.

Comparison of different nucleic acid preparation methods to improve specific HIV-1 RNA isolation for viral load testing on dried blood spots.

Guichet E, Serrano L, Laurent C, Eymard-Duvernay S, Kuaban C, Vidal L, Delaporte E, Ngole EM, Ayouba A, Peeters M.

J Virol Methods. 2018 Jan;251:75-79. doi: 10.1016/j.jviromet.2017.10.014. Epub 2017 Oct 14.

PMID:
29038002
9.

Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.

Ciaffi L, Koulla-Shiro S, Sawadogo AB, Ndour CT, Eymard-Duvernay S, Mbouyap PR, Ayangma L, Zoungrana J, Gueye NFN, Diallo M, Izard S, Bado G, Kane CT, Aghokeng AF, Peeters M, Girard PM, Le Moing V, Reynes J, Delaporte E; MOBIDIP study group.

Lancet HIV. 2017 Sep;4(9):e384-e392. doi: 10.1016/S2352-3018(17)30069-3. Epub 2017 May 28.

PMID:
28566227
10.

Smoking-associated morbidities on computed tomography lung cancer screens in HIV-infected smokers.

Bommart S, Cournil A, Eymard-Duvernay S, Raffi F, Bouassida I, Le Moing V, Reynes J, Makinson A; Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) HIV CHEST Study Team.

HIV Med. 2017 Nov;18(10):787-789. doi: 10.1111/hiv.12517. Epub 2017 May 15. No abstract available.

PMID:
28503852
11.

Incidence of infectious morbidity events after second-line antiretroviral therapy initiation in HIV-infected adults in Yaoundé, Cameroon.

Galy A, Ciaffi L, Le Moing V, Eymard-Duvernay S, Abessolo H, Toby R, Ayangma L, Le Gac S, Mpoudi-Etame M, Koulla-Shiro S, Delaporte E, Cournil A; 2LADY Study Group.

Antivir Ther. 2016;21(6):547-552. doi: 10.3851/IMP3030. Epub 2016 Feb 16.

PMID:
26882335
12.

Evolution of renal function in African patients initiating second-line antiretroviral treatment: findings from the ANRS 12169 2LADY trial.

Cournil A, Hema A, Eymard-Duvernay S, Ciaffi L, Badiou S, Kabore FN, Diouf A, Ayangma L, Le Moing V, Reynes J, Koulla-Shiro S, Delaporte E; 2LADY Study Group.

Antivir Ther. 2017;22(3):195-203. doi: 10.3851/IMP3097. Epub 2016 Oct 5.

PMID:
27705950
13.

Field evaluation of an open and polyvalent universal HIV-1/SIVcpz/SIVgor quantitative RT-PCR assay for HIV-1 viral load monitoring in comparison to Abbott RealTime HIV-1 in Cameroon.

Guichet E, Aghokeng A, Eymard-Duvernay S, Vidal N, Ayouba A, Mpoudi Ngole E, Delaporte E, Ciaffi L, Peeters M.

J Virol Methods. 2016 Nov;237:121-126. doi: 10.1016/j.jviromet.2016.09.005. Epub 2016 Sep 5.

14.

Short Communication: High Viral Load and Multidrug Resistance Due to Late Switch to Second-Line Regimens Could Be a Major Obstacle to Reach the 90-90-90 UNAIDS Objectives in Sub-Saharan Africa.

Guichet E, Aghokeng A, Serrano L, Bado G, Toure-Kane C, Eymard-Duvernay S, Villabona-Arenas CJ, Delaporte E, Ciaffi L, Peeters M.

AIDS Res Hum Retroviruses. 2016 Dec;32(12):1159-1162. Epub 2016 Aug 2.

PMID:
27342228
15.

Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers.

Makinson A, Eymard-Duvernay S, Raffi F, Abgrall S, Bommart S, Zucman D, Valour F, Cheret A, Poizot-Martin I, Duvivier C, Mauboussin JM, Bonnet F, Tattevin P, Reynes J, Le Moing V; ANRS EP48 HIV CHEST study Team.

AIDS. 2016 Feb 20;30(4):573-82. doi: 10.1097/QAD.0000000000000943.

PMID:
26829006
16.

Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa.

Ciaffi L, Koulla-Shiro S, Sawadogo A, le Moing V, Eymard-Duvernay S, Izard S, Kouanfack C, Ngom Gueye NF, Fobang AA, Reynes J, Calmy A, Delaporte E; 2LADY Study Group.

AIDS. 2015 Jul 31;29(12):1473-81. doi: 10.1097/QAD.0000000000000709.

17.

Chest Low-Dose Computed Tomography for Early Lung Cancer Diagnosis as an Opportunity to Diagnose Vertebral Fractures in HIV-Infected Smokers, an ANRS EP48 HIV CHEST Substudy.

Thouvenin Y, Makinson A, Cournil A, Eymard-Duvernay S, Lentz P, Delemazure AS, Corneloup O, Fabre S, Quesnoy M, Poire S, Brillet PY, Cyteval C, Reynes J, Le Moing V; ANRS HIV CHEST Study Team.

J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):299-305. doi: 10.1097/QAI.0000000000000599.

PMID:
26058045
18.

Monoclonal Gammopathy in HIV-1-Infected Patients: Factors Associated With Disappearance Under Long-Term Antiretroviral Therapy.

Casanova ML, Makinson A, Eymard-Duvernay S, Ouedraogo DE, Badiou S, Reynes J, Tuaillon E.

J Acquir Immune Defic Syndr. 2015 Nov 1;70(3):250-5. doi: 10.1097/QAI.0000000000000708.

PMID:
26039930
19.

Abdominal vs. overall obesity among women in a nutrition transition context: geographic and socio-economic patterns of abdominal-only obesity in Tunisia.

Traissac P, Pradeilles R, El Ati J, Aounallah-Skhiri H, Eymard-Duvernay S, Gartner A, Béji C, Bougatef S, Martin-Prével Y, Kolsteren P, Delpeuch F, Ben Romdhane H, Maire B.

Popul Health Metr. 2015 Jan 24;13:1. doi: 10.1186/s12963-015-0035-3. eCollection 2015.

20.

Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy.

Lê MP, Landman R, Koulla-Shiro S, Charpentier C, Sow PS, Diallo MB, Ngom Gueye NF, Ngolle M, Le Moing V, Eymard-Duvernay S, Benalycherif A, Delaporte E, Girard PM, Peytavin G; DAYANA Study Group.

J Antimicrob Chemother. 2015 May;70(5):1517-21. doi: 10.1093/jac/dku532. Epub 2015 Jan 11.

PMID:
25583749
21.

High prevalence of undiagnosed COPD in a cohort of HIV-infected smokers.

Makinson A, Hayot M, Eymard-Duvernay S, Quesnoy M, Raffi F, Thirard L, Bonnet F, Tattevin P, Abgrall S, Quantin X, Léna H, Bommart S, Reynes J, Le Moing V; ANRS EP48 HIV CHEST Study Team.

Eur Respir J. 2015 Mar;45(3):828-31. doi: 10.1183/09031936.00154914. Epub 2014 Oct 16. No abstract available.

22.

Challenges of antiretroviral treatment monitoring in rural and remote-access regions in Africa.

Taieb F, Aghokeng AF, Eymard-Duvernay S, Chia JE, Einterz E, Mpoudi-Ngole E, Peeters M, Molina JM, Delaporte E.

AIDS Res Hum Retroviruses. 2014 Jul;30(7):623-5. doi: 10.1089/AID.2014.0035. Epub 2014 Apr 14. No abstract available.

PMID:
24645979
23.

[Bone aging and frailty syndrome after 10 years of ARV treatment in Senegal].

Cournil A, Eymard-Duvernay S, Diouf A; groupe d’étude de la cohorte ANRS 1215.

Bull Soc Pathol Exot. 2014 Oct;107(4):238-40. doi: 10.1007/s13149-014-0350-4. Epub 2014 Mar 10. French.

PMID:
24615435
24.

Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.

Monleau M, Aghokeng AF, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Touré-Kane C, Truong LX, Chaix ML, Delaporte E, Ayouba A, Peeters M; ANRS 12235 Study Group.

J Clin Microbiol. 2014 Feb;52(2):578-86. doi: 10.1128/JCM.02860-13. Epub 2013 Dec 11.

25.

Obesity and association with area of residence, gender and socio-economic factors in Algerian and Tunisian adults.

Atek M, Traissac P, El Ati J, Laid Y, Aounallah-Skhiri H, Eymard-Duvernay S, Mézimèche N, Bougatef S, Béji C, Boutekdjiret L, Martin-Prével Y, Lebcir H, Gartner A, Kolsteren P, Delpeuch F, Ben Romdhane H, Maire B.

PLoS One. 2013 Oct 8;8(10):e75640. doi: 10.1371/journal.pone.0075640. eCollection 2013.

26.

Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.

Aghokeng AF, Monleau M, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Toni TD, Touré-Kane C, Truong LX, Delaporte E, Chaix ML, Peeters M, Ayouba A; ANRS 12186 Study Group.

Clin Infect Dis. 2014 Jan;58(1):99-109. doi: 10.1093/cid/cit627. Epub 2013 Sep 27.

PMID:
24076968
27.

Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial.

Landman R, Koulla-Shiro S, Sow PS, Ngolle M, Diallo MB, Guèye NF, Le Moing V, Eymard-Duvernay S, Benalycherif A, Charpentier C, Peytavin G, Delaporte E, Girard PM; DAYANA Study Group.

Antivir Ther. 2014;19(1):51-9. doi: 10.3851/IMP2675. Epub 2013 Aug 23.

PMID:
23970206
28.

Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon.

Aghokeng AF, Kouanfack C, Eymard-Duvernay S, Butel C, Edoul GE, Laurent C, Koulla-Shiro S, Delaporte E, Mpoudi-Ngole E, Peeters M.

J Int AIDS Soc. 2013 Jan 31;16:18004. doi: 10.7448/IAS.16.1.18004.

29.

Single real-time reverse transcription-PCR assay for detection and quantification of genetically diverse HIV-1, SIVcpz, and SIVgor strains.

Etienne L, Eymard-Duvernay S, Aghokeng A, Butel C, Monleau M, Peeters M.

J Clin Microbiol. 2013 Mar;51(3):787-98. doi: 10.1128/JCM.02792-12. Epub 2012 Dec 19.

30.

Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon.

Liégeois F, Vella C, Eymard-Duvernay S, Sica J, Makosso L, Mouinga-Ondémé A, Mongo AD, Boué V, Butel C, Peeters M, Gonzalez JP, Delaporte E, Rouet F.

J Int AIDS Soc. 2012 Nov 28;15(2):17985. doi: 10.7448/IAS.15.2.17985.

31.

Gender obesity inequities are huge but differ greatly according to environment and socio-economics in a North African setting: a national cross-sectional study in Tunisia.

El Ati J, Traissac P, Delpeuch F, Aounallah-Skhiri H, Béji C, Eymard-Duvernay S, Bougatef S, Kolsteren P, Maire B, Ben Romdhane H.

PLoS One. 2012;7(10):e48153. doi: 10.1371/journal.pone.0048153. Epub 2012 Oct 31.

32.

Reduced quantitative ultrasound bone mineral density in HIV-infected patients on antiretroviral therapy in Senegal.

Cournil A, Eymard-Duvernay S, Diouf A, Moquet C, Coutherut J, Ngom Gueye NF, Cames C, Taverne B, Bork K, Sow PS, Delaporte E; ANRS 1215 Study Group.

PLoS One. 2012;7(2):e31726. doi: 10.1371/journal.pone.0031726. Epub 2012 Feb 16.

33.

Blood pressure and associated factors in a North African adolescent population. a national cross-sectional study in Tunisia.

Aounallah-Skhiri H, El Ati J, Traissac P, Ben Romdhane H, Eymard-Duvernay S, Delpeuch F, Achour N, Maire B.

BMC Public Health. 2012 Feb 3;12:98. doi: 10.1186/1471-2458-12-98.

34.

Diabetes and Hypertension among Patients Receiving Antiretroviral Treatment Since 1998 in Senegal: Prevalence and Associated Factors.

Diouf A, Cournil A, Ba-Fall K, Ngom-Guèye NF, Eymard-Duvernay S, Ndiaye I, Batista G, Guèye PM, Bâ PS, Taverne B, Delaporte E, Sow PS.

ISRN AIDS. 2012 Dec 1;2012:621565. doi: 10.5402/2012/621565. eCollection 2012.

35.

Therapeutic drug monitoring of posaconazole in hematology adults under posaconazole prophylaxis: influence of food intake.

Eiden C, Meniane JC, Peyrière H, Eymard-Duvernay S, Le Falher G, Ceballos P, Fegueux N, Cociglio M, Reynes J, Hillaire-Buys D.

Eur J Clin Microbiol Infect Dis. 2012 Feb;31(2):161-7. doi: 10.1007/s10096-011-1288-9. Epub 2011 May 26.

PMID:
21611869
36.

Nutrition transition among adolescents of a south-Mediterranean country: dietary patterns, association with socio-economic factors, overweight and blood pressure. A cross-sectional study in Tunisia.

Aounallah-Skhiri H, Traissac P, El Ati J, Eymard-Duvernay S, Landais E, Achour N, Delpeuch F, Ben Romdhane H, Maire B.

Nutr J. 2011 Apr 24;10:38. doi: 10.1186/1475-2891-10-38.

37.

Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort study.

Makinson A, Tenon JC, Eymard-Duvernay S, Pujol JL, Allavena C, Cuzin L, Poizot-Martin I, de la Tribonnière X, Cabié A, Pugliese P, Reynes J, Le Moing V.

J Thorac Oncol. 2011 Jun;6(6):1022-9. doi: 10.1097/JTO.0b013e318217b6e0.

38.

Effect of extrusion cooking and amylase addition to gruels to increase energy density and nutrient intakes by Vietnamese infants.

Van Hoan N, Mouquet-Rivier C, Eymard-Duvernay S, Treche S.

Asia Pac J Clin Nutr. 2010;19(3):308-15.

39.

Pharmacokinetic variability of voriconazole and N-oxide voriconazole measured as therapeutic drug monitoring.

Eiden C, Cociglio M, Hillaire-Buys D, Eymard-Duvernay S, Ceballos P, Fegueux N, Peyrière H.

Xenobiotica. 2010 Oct;40(10):701-6. doi: 10.3109/00498254.2010.503814.

PMID:
20642349
40.

Food shopping transition: socio-economic characteristics and motivations associated with use of supermarkets in a North African urban environment.

Tessier S, Traissac P, Bricas N, Maire B, Eymard-Duvernay S, El Ati J, Delpeuch F.

Public Health Nutr. 2010 Sep;13(9):1410-8. doi: 10.1017/S1368980010000601. Epub 2010 Mar 31.

PMID:
20353618
41.

Health and behaviours of Tunisian school youth in an era of rapid epidemiological transition.

Aounallah-Skhiri H, Ben Romdhane H, Maire B, Elkhdim H, Eymard-Duvernay S, Delpeuch F, Achour N.

East Mediterr Health J. 2009 Sep-Oct;15(5):1201-14.

42.

Influence of acculturation among Tunisian migrants in France and their past/present exposure to the home country on diet and physical activity.

Méjean C, Traissac P, Eymard-Duvernay S, Delpeuch F, Maire B.

Public Health Nutr. 2009 Jun;12(6):832-41. doi: 10.1017/S1368980008003285. Epub 2008 Jul 23.

PMID:
18647429
43.

Nutritional status of Tunisian adolescents: associated gender, environmental and socio-economic factors.

Aounallah-Skhiri H, Romdhane HB, Traissac P, Eymard-Duvernay S, Delpeuch F, Achour N, Maire B.

Public Health Nutr. 2008 Dec;11(12):1306-17. doi: 10.1017/S1368980008002693. Epub 2008 Jun 19.

PMID:
18561866
44.

Assessment of child feeding practices using a summary index: stability over time and association with child growth in urban Madagascar.

Moursi MM, Martin-Prével Y, Eymard-Duvernay S, Capon G, Trèche S, Maire B, Delpeuch F.

Am J Clin Nutr. 2008 May;87(5):1472-9.

PMID:
18469273
45.

Regular users of supermarkets in Greater Tunis have a slightly improved diet quality.

Tessier S, Traissac P, Maire B, Bricas N, Eymard-Duvernay S, El Ati J, Delpeuch F.

J Nutr. 2008 Apr;138(4):768-74. Erratum in: J Nutr. 2008 Aug;138(8):1523.

PMID:
18356333
46.
47.

Diet quality of North African migrants in France partly explains their lower prevalence of diet-related chronic conditions relative to their native French peers.

Méjean C, Traissac P, Eymard-Duvernay S, El Ati J, Delpeuch F, Maire B.

J Nutr. 2007 Sep;137(9):2106-13.

PMID:
17709450
48.

Knowledge of dietary and behaviour-related determinants of non-communicable disease in urban Senegalese women.

Holdsworth M, Delpeuch F, Landais E, Gartner A, Eymard-Duvernay S, Maire B.

Public Health Nutr. 2006 Dec;9(8):975-81.

PMID:
17125559
49.

Dietary diversity scores and nutritional status of women change during the seasonal food shortage in rural Burkina Faso.

Savy M, Martin-Prével Y, Traissac P, Eymard-Duvernay S, Delpeuch F.

J Nutr. 2006 Oct;136(10):2625-32.

PMID:
16988137
50.

Seasonal and environmental effects on breast milk fatty acids in Burkina Faso and the need to improve the omega 3 PUFA content.

Thiombiano-Coulibaly N, Rocquelin G, Eymard-Duvernay S, Kiffer-Nunes J, Tapsoba S, Traoré SA.

Acta Paediatr. 2003 Dec;92(12):1388-93.

PMID:
14971787

Supplemental Content

Loading ...
Support Center